Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of TauroLock in port catheters
IRCT20201107049296N4Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of taurolidine in catheter infection and catheter-related thrombosis (CRT), sponsored by Iran University of Medical Sciences. Started Oct 2023; status: completed.
02
Drugs
taurolidine
03
Conditions
catheter infectioncatheter-related thrombosis (CRT)
Beyond the preview
Go deeper on IRCT20201107049296N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201107049296N4.